Music listening
BehavioralListening to music of one's choice one hour daily.
NCT Number: NCT06469619
Music listening has many positive effects on the brain. This study aims to find out if people with stroke get better results with their rehabilitation if they listen to music during their passive hours. The study is a randomized controlled trial with people who are at a rehabilitation center care after stroke at Tampere University Hospital. The control group gets standard rehabilitation. Music group gets standard rehabilitation and in addition they listen to music one hour a day during four weeks. Physiotherapists, occupational therapists and speech therapists test how well the participant's walking, use of hand and speech improve. The main goal is to find out if the improvement is better with music listening. The study also monitors effects of music listening on mood in rehabilitation.
Trial opening soon.
Get Notified18 year–85 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Listening to music of one's choice one hour daily.
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Functional Ambulation Classification
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Berg balance scale
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
10 m walking test
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Timed Up and Go
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Box and Block
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
9-hole Peg Test
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Grip strength
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Arm abduction (scale 1-3, 1 = normal, 2 = able to lift between horizontal plane but with at least 30 degrees deficiency, 3 = unable to lift above horizontal plane)
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Boston Naming Test
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Western Aphasia Battery
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Token
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Story based on a nine-frame cartoon (standardized point scale)
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Visual Analogue Mood Scale
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Beck Depression Inventory
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Generalized Anxiety Disorder-7
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Rivermead Motor Assessment Gross function
Time frame: At time point 0 and 4-5 weeks later (Before and after intervention)
Functional Status Questionnaire (FSQfin)
Contact information is provided by the study sponsor or research team.
Maria Sariola
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07398274
Brain Diseases, Brain Injuries
Örebro, Örebro County, Sweden
View Trial DetailsNCT06011720
Brain Diseases, Brain Ischemia
New Brunswick, New Jersey, United States
View Trial DetailsNCT05491980
Aneurysmal Subarachnoid Hemorrhage, Anoxic Brain Injury
Jacksonville, Florida, United States
View Trial DetailsNCT04760717
Brain Diseases, Cardiovascular Diseases
New Haven, Connecticut, United States
View Trial Details